Sleepwalking [somnambulism]

F5_SLEEPWALKING

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F51.3 Cause of death: ICD-10 — F51.3 2 out of 7 registries used, show all original rules.	113
4. Check minimum number of events None	113
5. Include endpoints None	113
6. Filter based on genotype QC (FinnGen only)	108

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	F5_SLEEPWALKING
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F513
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F513
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sleepwalking [somnambulism] based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	741	345	395
Only index persons	706	334	372
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	24.02	29.30	19.39
Only index persons	24.31	29.66	19.51

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	108	80	28
Unadjusted period prevalence (%)	0.02	0.03	0.01
Median age at first event (years)	32.94	34.88	27.40

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
113: Matched controls
1130

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F51.3

ICD-10 Finland

Sleepwalking [somnambulism]

+∞

163.0

113

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

142.8

22.5

G47.9

ICD-10 Finland

Sleep disorder, unspecified

23.2

18.9

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

72.7

11.9

N03AE01

ATC

clonazepam; systemic

12.0

11.6

N05AX08

ATC

risperidone; systemic

6.0

10.3

N06AX11

ATC

mirtazapine; oral

3.4

9.6

265

F51.0

ICD-10 Finland

Nonorganic insomnia

3.5

8.8

164

N05AH04

ATC

quetiapine; oral

3.5

8.6

160

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

8.9

8.2

N03AX12

ATC

[U] gabapentin; oral

4.0

8.1

N06AX16

ATC

venlafaxine; oral

3.6

7.5

H02AB07

ATC

prednisone; oral

4.2

7.3

H02AB06

ATC

prednisolone; systemic

2.8

6.9

323

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

6.5

6.8

N06AB03

ATC

fluoxetine; oral

3.8

6.7

Z76.0

ICD-10 Finland

Issue of repeat prescription

3.0

6.7

182

G43.9

ICD-10 Finland

Migraine, unspecified

3.9

6.5

F51.4

ICD-10 Finland

Sleep terrors [night terrors]

73.8

6.5

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.4

6.5

101

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

6.2

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

280

2.98

7.53

1.9

1.8

101.02

95.59

pmol/l

0.35

145

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

10.64

4.59

1.1

1.0

—

(3000492) Spirometry study

2.88

4.39

1.4

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

359

2.26

4.37

2.7

2.4

72.47

71.81

nmol/l

0.07

326

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

291

2.29

4.37

3.3

3.1

23.56

29.71

u/l

2.25

272

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

4.84

4.07

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

4.67

3.95

1.1

—

(3000991) Gas panel - Venous blood

3.49

3.93

18.3

8.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

4.50

3.83

1.1

1.2

—

(40768804) Tissue Pathology biopsy report

349

2.12

3.74

1.7

1.9

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3.24

3.74

1.3

1.7

—

(3025941) Bacteria identified in Stool by Culture

3.05

3.41

1.3

1.2

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

8.96

3.30

11.0

9.3

0.66

0.63

mmol/l

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

780

2.53

3.22

3.8

3.3

5.68

5.59

mmol/l

0.32

725

(40758558) Short blood count panel - Blood

222

2.07

3.11

8.8

6.0

—

(3018095) Leukocytes [#/volume] in Urine

306

1.99

3.09

4.0

3.2

20.93

55.12

e6/l

0.87

204

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

272

2.01

3.09

3.5

2.7

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

6.14

3.07

1.1

1.6

—

(3019198) Lymphocytes [#/volume] in Blood

481

1.89

2.76

7.2

5.9

2.13

2.07

e9/l

0.15

442

(3002385) Erythrocyte distribution width [Ratio]

101

859

2.66

2.73

16.3

12.7

15.11

13.97

0.92

101

850

(3013115) Eosinophils [#/volume] in Blood

473

1.88

2.72

7.4

6.4

0.18

e9/l

0.03

429

(3000494) Fungus identified in Specimen by Culture

2.39

2.69

1.2

1.5

—

(3006315) Basophils [#/volume] in Blood

456

1.86

2.66

7.3

6.0

0.04

e9/l

0.08

408

(40760892) CBC W Ordered Manual Differential panel - Blood

428

1.86

2.65

6.9

6.8

—

(3052851) Hemolysis interference index of Serum or Plasma

4.90

2.64

1.3

1.7

—

(3001604) Monocytes [#/volume] in Blood

457

1.86

2.63

7.4

6.0

0.50

0.55

e9/l

1.34

411

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

320

1.87

2.62

11.3

8.1

1.22

mmol/l

0.02

275

(3031040) Bacteria [#/volume] in Urine by Automated count

576

1.90

2.61

4.6

4.1

—

49.13

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

140

2.11

2.60

2.6

2.3

1.83

0.95

e6/l

0.99

(3021589) Normoblasts [#/volume] in Blood

423

1.83

2.53

7.9

8.0

0.00

e9/l

-0.00

348

(3002582) Erythrocytes [#/volume] in Urine

254

1.89

2.52

3.4

2.6

10.74

68.30

e6/l

1.52

192

(3026493) Urate [Moles/volume] in Serum or Plasma

165

2.02

2.50

2.1

2.8

278.78

4967.55

umol/l

0.81

147

(40768797) Stomach Pathology biopsy report

106

2.21

2.45

1.5

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

825

2.24

2.37

11.3

9.0

95.83

96.96

ml/min/173m2

0.20

636

(44816559) Phosphatidylethanol [Mass/volume] in Blood

3.13

2.35

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2.23

2.32

4.0

2.8

3.32

8.15

umol/l

0.73

(3011397) Hemoglobin [Presence] in Urine by Test strip

187

1.91

2.25

4.3

2.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

5.75

2.23

1.0

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

5.75

2.23

1.0

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

272

1.80

2.21

1.5

1.3

1.29

1.14

u/ml

0.11

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

189

1.88

2.18

2.8

2.2

0.64

0.76

mg/l

0.36

133

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

134

2.00

2.17

2.6

2.4

5.45

3.02

e6/l

0.32

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.86

2.13

1.9

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

232

1.81

2.12

2.0

2.7

10.79

61.31

ng/l

1.03

114

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

5.17

2.09

1.0

1.3

—

(3024928) Oxygen saturation in Venous blood

5.17

2.09

1.4

19.0

—

(3030467) Casts [#/volume] in Urine by Automated count

233

1.80

2.09

3.5

2.5

0.29

0.15

e6/l

0.40

168

(40761511) CBC panel - Blood by Automated count

108

987

3.13

2.06

12.0

9.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2.97

2.05

4.9

6.1

24.22

24.28

mmol/l

—

(3011288) Drugs identified in Urine by Screen method

2.28

2.03

2.6

1.8

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

653

1.77

2.01

4.1

2.7

29.52

35.79

u/l

1.02

627

(3022217) INR in Platelet poor plasma by Coagulation assay

262

1.75

1.99

2.1

7.7

0.94

1.10

inr

3.41

(3037467) Urinalysis macro (dipstick) panel - Urine

623

1.74

1.98

4.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

4.70

1.96

1.0

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

246

1.75

1.95

1.5

1.3

2.18

2.13

g/l

0.08

142

(36304419) Bacteria [Presence] in Urine

238

1.75

1.93

3.6

2.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2.12

1.92

2.6

2.2

319.43

3231.53

u/l

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

3.66

1.86

1.2

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

450

1.65

1.85

5.4

4.5

0.00

estimate

-0.00

102

(3014576) Chloride [Moles/volume] in Serum or Plasma

2.24

1.85

13.1

8.6

106.21

104.40

mmol/l

1.12

(3022145) Colonoscopy Study observation

2.07

1.81

1.4

1.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

530

1.65

1.80

10.7

8.2

3.56

4.07

e9/l

1.98

467

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

3.46

1.77

1.0

1.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

3.46

1.77

1.2

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.08

1.75

2.7

1.4

—

(3023368) Bacteria identified in Blood by Culture

177

1.77

1.73

4.3

4.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

3.97

1.73

1.0

—

(3012516) Albumin [Mass/volume] in Urine

153

1.81

1.72

3.3

3.4

2693.09

108.88

mg/l

0.46

100

(3009261) Glucose [Presence] in Urine by Test strip

457

1.61

1.69

4.2

3.1

0.00

estimate

-0.00

(3020779) Urea [Moles/volume] in Serum or Plasma

2.58

1.69

3.8

7.5

4.50

6.86

mmol/l

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2.92

1.68

1.6

7.4

0.66

0.58

—

(40761535) Cells panel - Urine sediment

2.45

1.63

5.0

2.7

—

(4094501) Cardiovascular stress test using bicycle ergometer

3.68

1.63

1.0

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

3.68

1.63

1.0

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2.69

1.54

1.6

7.1

0.81

1.26

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1.95

1.51

5.1

5.7

1.11

1.09

mmol/l

0.11

(3002032) Base excess in Venous blood by calculation

2.16

1.50

4.1

4.3

0.62

2.24

mmol/l

1.04

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.98

1.48

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

309

1.57

1.45

2.4

2.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2.29

1.44

1.6

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

196

1.65

1.41

3.1

2.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

103

941

2.07

1.39

14.8

10.6

19.94

22.06

mg/l

0.25

705

(3012544) pH of Venous blood

2.08

1.38

4.0

4.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

3.03

1.37

1.0

1.5

—

(3035350) Ketones [Presence] in Urine by Test strip

454

1.52

1.36

4.2

3.0

0.00

estimate

-0.00

103

(3044889) 12 lead EKG panel

503

1.52

1.35

3.0

2.9

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

2.86

1.30

8.8

4.2

322.80

355.54

umol/l

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

2.86

1.30

1.0

1.7

—

(36660697) Celiac disease serology panel - Serum

101

1.80

1.28

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

853

1.71

1.27

3.9

3.5

2.70

2.80

mmol/l

0.51

808

(46235355) HIV 1 and 2 tests - Meaningful Use set

383

1.49

1.25

2.2

2.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2.25

1.24

2.3

2.2

206.63

122.53

ng/l

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

2.70

1.23

1.4

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

2.38

1.20

1.3

2.2

0.33

2.37

e6/l

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

2.38

1.20

1.5

2.3

1.83

42.20

e6/l

—

(3020682) Albumin/Creatinine [Ratio] in Urine

162

1.61

1.17

3.5

3.9

5.15

14.13

mg/mmol

0.64

107

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

121

1.69

1.15

1.9

3.4

9.50

30.45

ng/l

1.08

(3026008) Bacteria identified in Urine by Culture

252

1.50

1.10

2.2

2.4

—

(4200892) Spirometry reversibility

2.04

1.06

2.1

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

184

1.54

1.04

1.5

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.80

1.04

3.0

2.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

811

1.54

1.03

3.3

3.1

1.11

1.21

mmol/l

0.81

768

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

844

1.58

1.03

3.4

3.3

1.48

1.47

mmol/l

0.03

800

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.06

1.02

1.1

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

284

1.45

1.00

2.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

109

1.66

1.00

5.2

3.6

0.81

mmol/l

0.18

103

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.95

0.96

1.0

1.4

—

(3045414) Leukocytes [Presence] in Urine

1.95

0.96

1.7

1.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2.29

0.95

1.2

1.3

—

17.82

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.73

0.92

1.5

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

851

1.52

0.91

3.6

3.3

4.53

4.65

mmol/l

0.64

811

(3021879) Hepatitis B virus core Ab [Presence] in Serum

121

1.58

0.89

1.4

—

(3002256) Pathology report gross observation

1.63

0.86

1.1

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

1.84

0.86

1.4

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

148

1.51

0.86

1.9

2.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1.99

0.85

1.3

2.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

123

1.55

0.84

1.3

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

304

1.38

0.80

2.1

1.7

—

(3042936) Bacteria identified in Isolate by Culture

1.59

0.80

3.0

2.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

159

1.48

0.80

1.4

1.3

46.10

10.21

u/ml

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2.23

0.77

1.4

3.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2.13

0.75

2.6

1.9

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.90

0.75

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1.90

0.75

1.9

1.6

—

(3022621) pH of Urine by Test strip

1.60

0.72

2.8

2.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1.89

0.69

1.0

1.1

—

(21494755) Public health laboratory ask at order entry panel

137

0.63

0.65

1.0

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

105

0.55

0.65

1.5

1.4

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.76

0.64

41.6

12.2

0.68

0.69

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1.76

0.64

41.6

12.2

1.54

1.37

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.56

0.62

1.3

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.70

0.62

1.4

2.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.61

0.0

4.5

—

3.92

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.61

0.0

4.5

—

53.60

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

0.00

0.60

0.0

4.2

—

22.62

—

(3044640) Blood type and Crossmatch panel - Blood

260

1.32

0.60

3.3

2.2

—

(3028300) Cannabinoids [Presence] in Urine

1.49

0.60

1.2

1.4

—

(3027008) Opiates [Presence] in Urine

1.49

0.60

1.2

1.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.50

0.58

1.3

2.1

369.38

400.46

nmol/l

0.34

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

116

1.44

0.58

1.5

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

1.47

0.57

1.2

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.52

0.57

1.4

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.54

0.56

1.3

1.2

—

(3003694) ABO and Rh group [Type] in Blood

350

0.77

0.54

1.8

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.57

0.54

1.0

1.4

—

(3016879) Cocaine [Presence] in Urine

1.47

0.53

1.2

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

232

0.73

0.53

2.1

1.4

—

(3013512) EKG study

166

1.33

0.48

2.3

3.3

—

(1002224) Polysomnography panel

1.43

0.46

1.0

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1.40

0.44

1.1

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.46

0.44

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.64

0.43

1.4

2.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

852

1.28

0.43

4.4

3.9

—

(40768443) Skin Pathology biopsy report

1.54

0.42

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

235

1.25

0.41

5.3

3.0

0.00

estimate

-0.00

100

(3015235) Bicarbonate [Moles/volume] in Capillary blood

0.00

0.41

0.0

2.4

—

22.79

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

0.41

0.0

2.9

—

9.35

—

(3012501) Base excess in Blood by calculation

0.00

0.41

0.0

2.9

—

2.44

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

0.41

0.0

2.9

—

4.98

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

0.41

0.0

2.3

—

6.61

—

(3010421) pH of Blood

0.00

0.41

0.0

2.9

—

7.43

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

0.41

0.0

2.3

—

1.29

—

(3027944) Amphetamines [Presence] in Urine

1.35

0.37

1.2

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.63

0.37

1.2

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.45

0.36

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.38

0.35

1.4

1.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

0.67

0.34

3.3

1.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

308

1.20

0.33

1.5

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

186

1.23

0.31

1.8

2.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.27

0.28

1.9

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

0.68

0.27

1.4

4.0

4.58

4.86

pmol/l

—

(3005033) Fetal Nuchal fold Thickness US

0.66

0.27

1.0

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.66

0.27

1.0

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.37

0.24

1.4

2.6

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.20

0.22

59.2

10.1

26.60

24.97

mmol/l

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.21

0.0

3.2

—

18.77

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.2

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

3.8

—

149.61

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.21

0.0

2.1

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.21

0.0

2.1

—

3.98

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.3

—

(3028271) Lactate [Moles/volume] in Capillary blood

0.00

0.21

0.0

2.5

—

1.75

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.21

0.0

2.1

—

107.00

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3021901) Oxygen saturation in Capillary blood

0.00

0.21

0.0

1.4

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

0.21

0.0

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

0.00

0.21

0.0

1.9

—

973.10

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

443

0.88

0.21

3.3

2.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

271

1.15

0.21

1.7

1.8

—

(3019225) pH of Specimen

1.24

0.20

1.2

5.0

—

(40767503) Oxygen content in Capillary blood by calculation

0.00

0.20

0.0

2.3

—

16.65

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.20

0.0

1.5

—

(1616796) Gas panel - Central venous blood

0.00

0.20

0.0

1.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.16

0.18

1.1

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

101

1.21

0.17

1.3

23.76

113.88

iu/ml

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.15

0.17

1.3

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

159

0.86

0.14

1.3

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

352

1.08

0.09

4.9

2.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

126

1.13

0.09

2.1

—

(4035726) Immunohistochemistry procedure

1.12

0.09

1.7

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1.03

0.08

4.1

1.4

597.86

281.03

mu/l

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.85

0.08

1.5

1.6

—

(40761536) Microorganisms panel - Urine sediment

1.05

0.07

4.4

3.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.85

0.07

1.4

1.5

—

(1761868) Lipid panel - Serum or Plasma

362

0.95

0.05

1.8

2.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

204

1.04

0.00

1.4

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

284

0.98

0.00

3.5

2.7

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.00

0.0

1.0

—

7.78

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

0.0

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.86

0.00

1.2

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

0.0

2.0

—

(3006270) Folate [Moles/volume] in Blood

0.00

0.0

1.6

—

486.40

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

0.0

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.0

1.0

—

(3020650) Glucose [Presence] in Urine

0.00

0.0

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.98

0.00

1.2

2.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

0.0

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

-0.00

0.0

2.8

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

-0.00

0.0

2.7

—

89.32

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.95

-0.00

1.1

1.4

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

2.5

—

850.50

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.00

-0.00

1.3

1.5

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

-0.00

0.0

2.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.95

-0.00

1.1

1.4

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

-0.00

0.0

1.1

—

32.75

—

(3037756) Immunofixation for Serum or Plasma

0.00

-0.00

0.0

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

-0.00

0.0

1.1

—

(4281824) Cell count and differential, peritoneal fluid

0.00

-0.00

0.0

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.95

-0.00

1.1

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

-0.00

0.0

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3000012) Reticulocyte production index

0.00

-0.00

0.0

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

10.63

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

2.7

—

(21494815) CD4 cells/100 lymphocytes in Specimen

0.00

-0.00

0.0

2.2

—

46.28

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

-0.00

0.0

1.3

—

5.71

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

50.02

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

-0.00

0.0

1.4

—

(3010503) CD19 cells [#/volume] in Blood

0.00

-0.00

0.0

2.2

—

0.12

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

17.95

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

8.43

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

-0.00

0.0

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.95

-0.00

1.1

1.4

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3008898) HLA-B27 [Presence]

0.90

-0.00

1.7

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.98

-0.00

5.1

4.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

-0.00

0.0

2.8

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_SLEEPWALKING and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have F5_SLEEPWALKING.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: F5_SLEEPWALKING – Sleepwalking [somnambulism]

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Sleepwalking [somnambulism]

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints